Division of Pharmacy, School of Allied Health, The University of Western Australia, Perth, Western Australia, Australia.
Curtin Medical School, Curtin University, Perth, Western Australia, Australia.
J Eval Clin Pract. 2022 Jun;28(3):483-492. doi: 10.1111/jep.13685. Epub 2022 Apr 6.
Clinical guidelines produced by cardiology societies (henceforth referred to simply as 'clinical guidelines') recommend thromboprophylaxis with oral anticoagulants (OACs) in patients with atrial fibrillation (AF) who have moderate-to-high stroke risk. However, deviations from these recommendations are observed, especially in the primary healthcare setting. The primary aims of this study were to evaluate the self-reported use of AF clinical guidelines and risk stratification tools among Australian general practitioners (GPs), and their perceptions regarding the available resources.
We conducted an online survey of Australian GPs. Descriptive statistics were used to summarise the findings.
Responses from 115 GPs were included for analysis. Respondents reported various ways of accessing thromboprophylaxis-related information (n = 113), including clinical guidelines (13.3%), 'Therapeutic Guidelines ' (37.2%) and Royal Australian College of General Practitioners websites (16.8%). Of those who reported reasons against accessing information from clinical guidelines (n = 97), the most frequent issues were: too many AF guidelines to choose from (34.0%; 33/97), different guidelines for different diseases (32.0%; 31/97), time-consuming to read guidelines (21.6%; 21/97), disagreements between different guideline recommendations (20.0%; 19/97), conflict with criteria for government subsidy (17.5%; 17/97) and GPs' busy schedules (15.5%; 15/97). When assessing patients' risk of stroke (n = 112) and bleeding (n = 111), the majority of the respondents reported primarily relying on a formal stroke risk (67.0%) and bleeding risk (55.0%) assessment tools, respectively. Respondents reported using formal stroke and bleeding risk assessment tools mainly when newly initiating patients on therapy (72.4%; 76/105 and 65.3%; 65/101, respectively).
Among our small sample of Australian GPs, most did not access thromboprophylaxis-related information directly from AF-specific clinical guidelines developed by cardiology societies. Although the majority reported using formal stroke and bleeding assessment tools, these were typically used on OAC initiation only. More focus is needed on formal risk reassessment as clinically indicated and at regular review.
心脏病学会制定的临床指南(以下简称“临床指南”)建议,具有中高度卒中风险的心房颤动(AF)患者应使用口服抗凝剂(OAC)进行血栓预防。然而,这些建议存在偏差,尤其是在初级保健环境中。本研究的主要目的是评估澳大利亚全科医生(GP)对 AF 临床指南和风险分层工具的自我报告使用情况,以及他们对现有资源的看法。
我们对澳大利亚的全科医生进行了在线调查。使用描述性统计方法对调查结果进行总结。
共纳入 115 名 GP 的应答进行分析。受访者报告了各种获取血栓预防相关信息的方法(n=113),包括临床指南(13.3%)、“治疗指南”(37.2%)和澳大利亚皇家全科医师学院网站(16.8%)。在报告不查阅临床指南信息的原因的受访者中(n=97),最常见的问题是:可供选择的 AF 指南太多(34.0%;33/97)、不同疾病有不同的指南(32.0%;31/97)、阅读指南耗时(21.6%;21/97)、不同指南建议存在分歧(20.0%;19/97)、与政府补贴标准冲突(17.5%;17/97)和 GP 日程繁忙(15.5%;15/97)。在评估患者的卒中(n=112)和出血风险(n=111)时,大多数受访者报告主要依赖正式的卒中风险(67.0%)和出血风险(55.0%)评估工具。受访者报告主要在开始给患者治疗时使用正式的卒中和出血风险评估工具(72.4%;76/105 和 65.3%;65/101)。
在我们的澳大利亚全科医生小样本中,大多数人没有直接查阅心脏病学会制定的针对 AF 的特定临床指南获取血栓预防相关信息。尽管大多数人报告使用了正式的卒中风险和出血风险评估工具,但这些工具通常仅在开始使用 OAC 时使用。需要更加关注在临床需要时和定期检查时进行正式的风险再评估。